Company intelligence / Profile preview
CPTx
Planegg/Munich, Bavaria, Germanycptx.bio ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
CPTx has demonstrated the ability to synthesize large-scale single-stranded DNA constructs with high precision. Their proprietary nonviral gene carrier system shows promise in overcoming immunogenicity and targeting challenges seen with traditional gene therapies. Lead programs include a pan-influenza antiviral candidate and an in vivo CAR-T therapy approaching IND-enabling studies; no human clinical data reported yet as of May 2025[3][5].
- Therapeutic areas
- OncologyRare DiseasesImmunologyInfectious Diseases
- Modalities
- Single-stranded DNA therapeuticsIn vivo CAR-T cell therapyGene nanocarriers (nonviral, non-LNP)Multivalent drug display using DNA nanostructuresSmall molecules, peptides, proteins & antibodies (as payloads via their platform)[7]
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Not specifically named; two partnership assets mentioned but partners undisclosed as of May 2025[3]. Investors include Bayern Kapital among others.
Beyond the preview
Go deeper on CPTx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CPTx.